Placenta cells may lower blood pressure

by Sue Smethurst,La Trobe UniversityAngiotensin II induced-hypertension and aortic stiffening is reduced by administration of amnion epithelial cells. (A) Immunostaining for HLA-G in angiotensin

Updated on: March 26,2024

Placenta cells may lower blood pressure

by Sue Smethurst,La Trobe UniversityAngiotensin II induced-hypertension and aortic stiffening is reduced by administration of amnion epithelial cells. (A) Immunostaining for HLA-G in angiotensin

Updated on:March 26,2024

Lasting benefits seen for cardiac resynchronization therapy with defibrillator

by Elana GotkineReceipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, acc

Updated on: March 15,2024

Lasting benefits seen for cardiac resynchronization therapy with defibrillator

by Elana GotkineReceipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, acc

Updated on:March 15,2024

New transparent 'blood vessel-on-a-chip' could reduce animal testing

byUniversity of SydneyPAC and APPJ treatments promote HCAEC growth and function in an artery-on-a-chip. A) Schematic diagram illustrating the microfluidic assembly process and cell culture. B) C

Updated on: July 08,2024

New transparent 'blood vessel-on-a-chip' could reduce animal testing

byUniversity of SydneyPAC and APPJ treatments promote HCAEC growth and function in an artery-on-a-chip. A) Schematic diagram illustrating the microfluidic assembly process and cell culture. B) C

Updated on:July 08,2024

Pandemic associated with increase in babies born with heart defects

byCity St George's, University of LondonCredit: Unsplash/CC0 Public DomainThe proportion of babies born with a congenital heart abnormality increased by 16% after the first year of the pande

Updated on: November 26,2024

Pandemic associated with increase in babies born with heart defects

byCity St George's, University of LondonCredit: Unsplash/CC0 Public DomainThe proportion of babies born with a congenital heart abnormality increased by 16% after the first year of the pande

Updated on:November 26,2024

Cardiac amyloidosis: New AI system developed for early diagnosis

byMedical University of ViennaCohort origin overview. Patients from nine centers in four countries and two continents were enrolled. The largest cohort in terms of patient number, the Austrian c

Updated on: March 28,2024

Cardiac amyloidosis: New AI system developed for early diagnosis

byMedical University of ViennaCohort origin overview. Patients from nine centers in four countries and two continents were enrolled. The largest cohort in terms of patient number, the Austrian c

Updated on:March 28,2024

Deep-learning model based on chest X-ray helps predict MACE

by Elana GotkineA deep-learning model based on a chest radiograph (CXR) for cardiovascular disease (CVD) risk (CXR CVD-Risk) predicts major adverse cardiovascular events (MACE) beyond the clinical sta

Updated on: March 28,2024

Deep-learning model based on chest X-ray helps predict MACE

by Elana GotkineA deep-learning model based on a chest radiograph (CXR) for cardiovascular disease (CVD) risk (CXR CVD-Risk) predicts major adverse cardiovascular events (MACE) beyond the clinical sta

Updated on:March 28,2024

Novel score system accurately identifies lesions, reducing risk of percutaneous coronary intervention complications

bySociety for Cardiovascular Angiography and InterventionsCredit: Pixabay/CC0 Public DomainNew data demonstrated that a left main (LM) bifurcation-specific novel scoring system (LM V-RESOLVE), b

Updated on: May 08,2024

Novel score system accurately identifies lesions, reducing risk of percutaneous coronary intervention complications

bySociety for Cardiovascular Angiography and InterventionsCredit: Pixabay/CC0 Public DomainNew data demonstrated that a left main (LM) bifurcation-specific novel scoring system (LM V-RESOLVE), b

Updated on:May 08,2024

New progress in wearable blood pressure monitoring enabled by flexible electronics and machine learning

by KeAi Communications Co.Links to achieve wearable cuffless blood pressure monitoring via flexible sensors. Credit: J. Hua, M. Su, J. Wu, Y. Zhou, Y. Guo, Y. Shi, L. PanCardiovascular disease is the

Updated on: August 08,2024

New progress in wearable blood pressure monitoring enabled by flexible electronics and machine learning

by KeAi Communications Co.Links to achieve wearable cuffless blood pressure monitoring via flexible sensors. Credit: J. Hua, M. Su, J. Wu, Y. Zhou, Y. Guo, Y. Shi, L. PanCardiovascular disease is the

Updated on:August 08,2024

New 4D imaging may detect poor pumping in deadly heart disease

by Lynda De Widt,Mayo ClinicCredit:iScience(2023). DOI: 10.1016/j.isci.2023.108493In a new study published iniScience, Mayo Clinic researchers found that a novel 4D echo imagin

Updated on: March 15,2024

New 4D imaging may detect poor pumping in deadly heart disease

by Lynda De Widt,Mayo ClinicCredit:iScience(2023). DOI: 10.1016/j.isci.2023.108493In a new study published iniScience, Mayo Clinic researchers found that a novel 4D echo imagin

Updated on:March 15,2024

AI tools better at predicting heart transplant rejection than standard clinical method, finds study

by Emory UniversityCredit: Emory UniversityMore than 4,500 heart transplants were performed in the U.S. in 2023. While the lifesaving operation improves the quality of life and longevity for most

Updated on: March 28,2024

AI tools better at predicting heart transplant rejection than standard clinical method, finds study

by Emory UniversityCredit: Emory UniversityMore than 4,500 heart transplants were performed in the U.S. in 2023. While the lifesaving operation improves the quality of life and longevity for most

Updated on:March 28,2024

Research team discovers how Copaxone protects the heart muscle and improves its function after heart attack

byWeizmann Institute of ScienceCardiac sections of mice after an injury simulating a heart attack. In mice that were treated with Copaxone (bottom row), the sections reveal greater integrity of

Updated on: September 06,2024

Research team discovers how Copaxone protects the heart muscle and improves its function after heart attack

byWeizmann Institute of ScienceCardiac sections of mice after an injury simulating a heart attack. In mice that were treated with Copaxone (bottom row), the sections reveal greater integrity of

Updated on:September 06,2024

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief

Updated on: October 21,2024

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief

Updated on:October 21,2024